CVE-2025-8306
Overview
CVE-2025-8306 is a known-severity vulnerability. It was published on January 8, 2026.
Technical Description
Asseco InfoMedica is a comprehensive solution used to manage both administrative and medical tasks in the healthcare sector. A low privileged user is able to obtain encoded passwords of all other accounts (including main administrator) due to lack of granularity in access control.
Chained exploitation of this vulnerability and CVE-2025-8307 allows an attacker to escalate privileges. This vulnerability has been fixed in versions 4.50.1 and 5.38.0
Remediation
Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.
References
Frequently Asked Questions
What is CVE-2025-8306?
CVE-2025-8306 is a known-severity vulnerability. It was published on January 8, 2026.
How severe is CVE-2025-8306?
CVSS score information is not yet available for this vulnerability. Check back as the CVE record is updated by NVD analysts.
How do I fix or remediate CVE-2025-8306?
Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.
How can CyberStrike help with CVE-2025-8306?
CyberStrike's AI-powered security agents can automatically detect CVE-2025-8306 across your infrastructure using autonomous pentesting, DAST scanning, and HackBrowser. The platform continuously monitors for known vulnerabilities and provides actionable remediation guidance prioritized by real-world exploitability.
How CyberStrike Helps
AI agents map your attack surface to find vulnerabilities like this one.
Automated penetration testing that runs continuously, not just quarterly.
AI-driven PR review catches vulnerable dependencies before they ship.
Browser-based exploitation validates findings with real proof-of-concept.